Table 1.
Baseline characteristics
| Baseline Characteristics |
Non-pruritus (n = 53; 44%) |
Pruritus (n = 67; 56%) |
Total patients (n = 120) |
|---|---|---|---|
| Age (in years) | |||
| 52.3 ± 14.5 | 56.5 ± 11.3 | ||
| Gender distribution | |||
| Males | 39 (73.5%) | 55 (82%) | 94 (78.4%) |
| Females | 14 (26.5%) | 12 (18%) | 26 (21.6%) |
| Etiology of CKD | |||
| DKD | 6 (11.3%) | 16 (23.8%) | 22 (18.3%) |
| CGN | 11 (20.7%) | 24 (35.8%) | 35 (29.1%) |
| CTIN | 18 (34%) | 9 (13.4%) | 27 (22.5%) |
| HNS | 9 (17.1%) | 9 (13.4%) | 18 (15%) |
| ADPKD | 3 (5.6%) | 1 (1.6%) | 4 (3.3%) |
| Others | 6 (11.3%) | 8 (12%) | 14 (11.6%) |
| Smokers | |||
| Yes | 2 (3.8%) | 3 (4.5%) | 5 (4.1%) |
| No | 51 (96.2%) | 64 (95.5%) | 115 (95.9%) |
| Seropositive patients | |||
| HBV | None | 3 (100%) | 3 (2.5%) |
| HCV | None | 1 (100%) | 1 (0.8%) |
| Medications/Therapies | |||
| Topical applications | - | 17 (25.4% | - |
| Oral antihistaminic | - | 45 (67.2%) | - |
| Pregabalin | - | 5 (7.4%) | - |
DKD Diabetic kidney disease, CGN chronic glomerulonephritis, CTIN chronic tubulointerstitial nephritis, HNS hypertensive nephrosclerosis, ADPKD autosomal dominant polycystic kidney disease, HBV hepatitis B virus, HCV hepatitis C virus